Regulatory Affairs

FDA Releases New Opioid Labeling Requirements

The FDA has unveiled enhanced warnings for opioid pain medications that will affect 141 generic and 87 innovative immediate-release opioid products, which account for roughly 90% of all prescription opioids. Read More